News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cleveland Biolabs Inc. (CBLI) Announces Departure Of Jean Viallet To Assume Oncology Development Leadership Role At Leading Biopharmaceutical


12/18/2013 1:44:34 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BUFFALO, N.Y., Dec. 18, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today reported that Chief Development Officer, Jean Viallet, MD will leave the Company to assume an oncology global clinical research leadership role at Bristol-Myers Squibb, effective January 3, 2014.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES